Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 13 studies | 47% ± 18% | |
endothelial cell | 9 studies | 22% ± 7% | |
glutamatergic neuron | 8 studies | 38% ± 22% | |
type II pneumocyte | 7 studies | 40% ± 11% | |
GABAergic neuron | 6 studies | 47% ± 19% | |
endothelial cell of lymphatic vessel | 5 studies | 36% ± 9% | |
oligodendrocyte precursor cell | 5 studies | 24% ± 9% | |
interneuron | 4 studies | 55% ± 20% | |
neuron | 3 studies | 32% ± 16% | |
pericyte | 3 studies | 23% ± 5% | |
granule cell | 3 studies | 26% ± 4% | |
astrocyte | 3 studies | 33% ± 18% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 40% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1834.28 | 2638 / 2642 | 95% | 10.65 | 673 / 705 |
breast | 100% | 1866.08 | 458 / 459 | 89% | 11.01 | 994 / 1118 |
lung | 100% | 2424.59 | 577 / 578 | 87% | 7.88 | 1005 / 1155 |
prostate | 98% | 943.21 | 241 / 245 | 88% | 8.53 | 440 / 502 |
bladder | 100% | 1010.57 | 21 / 21 | 83% | 7.10 | 420 / 504 |
thymus | 100% | 1315.79 | 651 / 653 | 73% | 5.52 | 442 / 605 |
esophagus | 86% | 824.76 | 1245 / 1445 | 78% | 7.88 | 143 / 183 |
adrenal gland | 76% | 482.17 | 197 / 258 | 84% | 11.80 | 193 / 230 |
intestine | 98% | 828.90 | 949 / 966 | 51% | 3.67 | 268 / 527 |
uterus | 98% | 828.82 | 166 / 170 | 51% | 3.67 | 235 / 459 |
pancreas | 72% | 301.72 | 236 / 328 | 72% | 4.91 | 129 / 178 |
skin | 80% | 596.13 | 1441 / 1809 | 61% | 4.58 | 288 / 472 |
ovary | 73% | 350.76 | 132 / 180 | 62% | 3.50 | 268 / 430 |
kidney | 76% | 364.36 | 68 / 89 | 50% | 3.79 | 447 / 901 |
stomach | 66% | 349.22 | 236 / 359 | 55% | 3.93 | 158 / 286 |
adipose | 100% | 2334.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1097.54 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.53 | 1 / 1 |
blood vessel | 100% | 1302.43 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 84% | 386.67 | 674 / 803 | 0% | 0 | 0 / 0 |
heart | 84% | 471.17 | 719 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 3.72 | 28 / 45 |
lymph node | 0% | 0 | 0 / 0 | 55% | 2.81 | 16 / 29 |
liver | 5% | 17.08 | 12 / 226 | 19% | 1.07 | 76 / 406 |
eye | 0% | 0 | 0 / 0 | 24% | 1.18 | 19 / 80 |
peripheral blood | 18% | 143.36 | 167 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051961 | Biological process | negative regulation of nervous system development |
GO_0030513 | Biological process | positive regulation of BMP signaling pathway |
GO_0045684 | Biological process | positive regulation of epidermis development |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0070700 | Molecular function | BMP receptor binding |
Gene name | ELAPOR2 |
Protein name | Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L) Endosome-lysosome associated apoptosis and autophagy regulator family member 2 |
Synonyms | KIAA1324L EIG121L |
Description | FUNCTION: Functions as a regulator of the BMP signaling pathway and may be involved in epidermal differentiation. . |
Accessions | ENST00000425689.1 ENST00000423294.5 A8MWY0 H7BYL8 ENST00000427812.1 H7BZ34 ENST00000444627.5 ENST00000398276.6 ENST00000450689.7 [A8MWY0-1] C9JA41 H7C2N5 ENST00000416314.5 [A8MWY0-3] ENST00000394714.6 C9JFK7 F1LLU5 |